Monthly Archives: December 2012
By Clark Herman | Published: December 13, 2012
The National Intelligence Council’s Global Trends Report explains the scenarios in which the next 18 years may play out internationally. Some of the predictions addressed matters of global health and health technologies playing a role in the future of medicine.
By Ben Comer | Published: December 13, 2012
Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
By Jill Wechsler | Published: December 12, 2012
If people can promote drugs for uses that lack supporting evidence, it would turn back the clock to the pre-1962 world of medicine where there wasn’t any research or data on what medicines worked and what was harmful, says Robert Temple, deputy director for clinical science at FDA’s Center for Drug Evaluation and Research (CDER).
By Clark Herman | Published: December 11, 2012
Yesterday Acura Pharmaceuticals launched its new pseudoephedrine-based product Nexafed, an over-the-counter product aimed at deterring abuse of the illicit drug methamphetamine. Pseudoephedrine, the decongestant known also as the primary ingredient in the production of methamphetamine, has been subject to a federal statute which keeps medicines with the ingredient behind the counter of all pharmacies in […]
By Ben Comer | Published: December 5, 2012
If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?